CRNX icon

Crinetics Pharmaceuticals
CRNX

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$84
50% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Goldman Sachs
Goldman Sachs
Richard Law
100% 1-yr CRNX win rate
12 Jan ‘26 5 days ago
Citizens
Citizens
Jonathan Wolleben
80% 1-yr CRNX win rate
8 Jan ‘26 9 days ago
Morgan Stanley
Morgan Stanley
Jeffrey Hung
100% 1-yr CRNX win rate
6 Jan ‘26 11 days ago